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Summary
 
CD34
 
1
 
 hematopoietic stem cells, which circulate in peripheral blood with very low frequency,
exert essential accessory function during lipopolysaccharide (LPS)-induced human T lympho-
cyte activation, resulting in interferon 
 
g
 
 production and proliferation. In contrast, stimulation
of T cells by “conventional” recall antigens is not controlled by blood stem cells. These con-
clusions are based on the observation that depletion of CD34
 
1
 
 blood stem cells results in a loss
of LPS-induced T cell stimulation as well as reduced expression of CD80 antigen on mono-
cytes. The addition of CD34-enriched blood stem cells resulted in a recovery of reactivity of T
cells and monocytes to LPS. Blood stem cells could be replaced by the hematopoietic stem cell
line KG-1a. These findings may be of relevance for high risk patients treated with stem cells or
stem cell recruiting compounds and for patients suffering from endotoxin-mediated diseases.
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L
 
ipopolysaccharide (LPS, endotoxin) is the major com-
ponent of the outer membrane of Gram-negative bac-
teria. The release of LPS by bacteria is considered to be re-
sponsible for systemic reactions of severely infected patients
and may cause septic shock associated with high risk for a
lethal outcome. LPS exerts its fatal action not directly, but
stimulates various types of cells, including monocytes/mac-
rophages (1, 2), endothelial cells (3), or granulocytes (4), to
release inflammatory mediators, including IL-1, IL-6, and
TNF-
 
a
 
. In addition, murine B lymphocytes were shown
to respond to LPS by reacting with differential proliferation
and antibody production (5–7). In recent years, it became
evident that LPS is also a potent inducer of human as well
as murine T lymphocyte proliferation and cytokine pro-
duction (8–12). We have previously shown that this LPS-
induced T cell activation is strongly dependent on direct
cell-to-cell contact of responding T lymphocytes with via-
ble accessory monocytes, indicating receptor–ligand inter-
actions (13). Furthermore, this interaction was MHC unre-
stricted, but strongly dependent on B7 interaction with
CD28 (14). Moreover, it could be demonstrated by analysis
of the frequency of responding T lymphocytes that LPS is
not active as a mitogen, superantigen, or classical antigen,
indicating a new mechanism of T cell stimulation (14).
When comparing the stimulatory activity of LPS on
PBMCs from adult donors with PBMCs isolated from cord
blood, we made the following unexpected finding: adult
donors could be grouped, with regard to an LPS-inducible
T cell proliferation, into LPS responders and LPS nonre-
sponders (13); however, PBMCs isolated from cord blood
always responded to LPS with a proliferation of T lympho-
cytes. This phenomenon suggested an important role of a
cell population present in PBMCs from cord blood samples
but rare in PBMCs isolated from adult donors. Only in the
presence of larger amounts of this rare cell population is an
LPS-induced T cell response observed. As described in this
report, this cell type has now been identified as the CD34
 
1
 
blood hematopoietic stem cell.
 
Materials and Methods
 
Isolation of Different Cell Populations.
 
Human PBMCs were iso-
lated from heparinized blood by discontinuous centrifugation
over Ficoll-Hypaque according to the method described by
 
Böyum (15). CD34
 
1
 
 cells were depleted from PBMCs using
the CD34 Progenitor Cell Isolation kit (Miltenyi Biotech).
Cells were labeled with the hapten-conjugated anti-CD34 mAb
QBEND-10, and immunomagnetic beads were coated with hap-
ten-specific goat anti–mouse (GaM)
 
1
 
 antibodies according to in-
structions given by the manufacturer.
 
1
 
Abbreviations used in this paper:
 
 GaM, goat anti–mouse; HS, human serum;
PPD, purified protein derivative; TT, tetanus toxoid. 
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We were unable to control this depletion procedure by flow
cytometry, since the number of CD34
 
1
 
 cells was always below
the detection limit of this method (in our hands 
 
,
 
0.5%). For iso-
lation of CD34
 
1
 
 cells, two subsequent enrichments from PBMCs
were performed, resulting in a purity of CD34
 
1
 
 stem cells be-
tween 45 and 85%. In some experiments, lymphocytes were sep-
arated from monocytes using a JE-6B elutriator (Beckman Instru-
ments). The monocyte fraction collected consisted of 
 
.
 
95%
monocytes, as determined by FACS
 
®
 
 analysis after staining with
anti-CD14 (Leu-M3; Becton Dickinson). T cells were isolated
from lymphocytes by depletion of CD14
 
1
 
, CD16
 
1
 
, and CD19
 
1
 
cells using the magnetic activated cell sorting system (MACS
 
®
 
;
Miltenyi Biotech) with the following antibodies: CD14 micro-
beads, CD16 microbeads, and CD19 microbeads (all Miltenyi
Biotech). These purified T lymphocytes consisted of 
 
.
 
98%
CD2
 
1
 
 T lymphocytes (Leu-5b; Becton Dickinson) and 
 
,
 
0.01%
esterase-positive cells.
 
Cell Culture.
 
Cells were cultured in RPMI 1640 supple-
mented with 10% heat-inactivated human serum (HS) and anti-
biotics in flat-bottomed plates (Nunc) at a final volume of 200 
 
m
 
l.
Cells were stimulated with LPS from 
 
Salmonella friedenau
 
 (1 
 
m
 
g/ml),
tetanus toxoid (TT, 1 limit of flocculation [Lf]/ml), purified pro-
tein derivatives (PPDs) of 
 
Mycobacterium tuberculosis
 
 (1 
 
m
 
g/ml), or
BCG (4,000 CFU/ml). Cells were cultured for 7 d in a humidi-
fied 5% CO
 
2
 
 atmosphere at 37
 
8
 
C. For the last 8 h of stimulation,
cells were labeled with [
 
3
 
H]TdR (2 Ci/mmol, 0.2 
 
m
 
Ci/culture)
and harvested on glass filter mats for measurement of incorpo-
rated radioactivity.
 
Induction of CD80 and Immunofluorescence Staining of Cells.
 
PBMCs (10
 
6
 
/ml) were cultured in 24-well plates (1 ml/well;
Nunc) in the presence or absence of LPS (1 
 
m
 
g/ml) in RPMI
1640 supplemented with 10% HS. After 2 d of culture, cells were
collected by careful rubbing to yield all adherent monocytes. In-
direct immunofluorescent staining of PBMCs was performed in
ice-cold PBS (containing 0.1% sodium azide) with anti-CD80–
biotin (anti-B7.1, clone BB.1; PharMingen) in concentrations as
recommended by the producer. After incubation for 20 min at
4
 
8
 
C, cells were washed by centrifugation on an FCS gradient
(200 
 
g
 
 for 10 min). Cells were then incubated for another 20 min
with streptavidin–Red 670. Unbound streptavidin–Red 670 was
again removed by centrifugation over an FCS gradient. Labeled
cells were analyzed in a Cytofluorograf (model 50H; Ortho Di-
agnostic Systems).
 
IFN-
 
g
 
 Production.
 
PBMCs (10
 
6
 
/ml) were cultured in 24-well
plates (1 ml/well; Nunc) in the presence or absence of LPS (1
 
m
 
g/ml) in RPMI 1640 supplemented with 10% HS. Supernatants
were harvested after 24, 48, or 96 h of culture, and IFN-
 
g 
 
pro-
duction was measured with an ELISA provided by Dr. H. Galatti
(Hoffmann-La Roche, Basel, Switzerland).
 
Culture Conditions for the Induction of Dendritic Cells.
 
Mono-
cytes (10
 
6
 
/ml) were isolated by counter-flow elutriation and cul-
tured in six-well plates in RPMI 1640 plus 10% HS and GM-
CSF (100 U/ml), IL-4 (50 U/ml), and IFN-
 
g
 
 (50 U/ml).
Weekly, half of the culture medium was replaced by new me-
dium with cytokines.
 
Results
 
Depletion of CD34
 
1
 
 Blood Stem Cells Prevents LPS-induced
T Cell Proliferation, but Enrichment of CD34
 
1
 
 Blood Stem
Cells Restores the Response of LPS Nonresponders.
 
In previ-
ous investigations, we found that only 
 
z
 
50% of adult
blood donors responded to LPS stimulation by a T cell
proliferation. However, in all PBMCs isolated from cord
blood samples (
 
n
 
 
 
. 
 
30), an LPS-induced T cell prolifera-
tion could be observed. Thus, we were looking for a very
rare accessory cell population which was significantly en-
riched in cord blood compared with adult blood. CD34
 
1
 
cells were likely candidates for this cell population, since
they are very rare in adult blood (0.03–0.09%) but present
in significantly larger amounts in cord blood (0.33–1.98%)
(16). Therefore, we depleted CD34
 
1
 
 cells from PBMCs of
adult donors using a CD34 isolation kit and the MACS
 
®
 
system. These CD34-depleted PBMCs were either stimu-
lated with LPS or the recall antigen PPD of tuberculin.
Furthermore, CD34-enriched cell preparations were added
to CD34-depleted PBMCs and then again stimulated with
LPS or antigens. Table I shows representative results of one
out of seven experiments. Magnetic depletion of CD34
 
1
 
cells from PBMCs resulted in a clear and almost total loss of
the LPS-induced DNA synthesis. The DNA synthesis in-
duced by PPD was not reduced in CD34-depleted cul-
tures, ruling out the possibility that classical APCs were de-
pleted or had lost their accessory capacity during magnetic
depletion procedures. The response to LPS was fully re-
stored or even enhanced by addition of 5% CD34-enriched
cells to CD34-depleted PBMCs. These findings were sup-
ported by the following control experiments: (a) PBMCs
were labeled with anti-CD34 mAbs and goat anti–mouse
(GaM) microbeads, but not subjected to the MACS
 
®
 
 sepa-
ration columns. This labeling procedure did not affect the
LPS-induced T cell proliferation. (b) PBMCs were labeled
with isotype-specific antibodies and after binding to GaM
microbeads were subjected to MACS
 
®
 
 separation columns.
These control PBMCs could be stimulated by LPS just as
well as untreated PBMCs. (c) CD34-enriched cells by
themselves were stimulated with LPS. As shown in Table I,
these cells did not respond to LPS (or PPD). This finding
excludes the possibility of CD34
 
1
 
 stem cells representing
the proliferating cells after stimulation with LPS.
Next, we investigated whether the addition of CD34-
enriched cells to CD34-depleted PBMCs restored an LPS-
inducible proliferation of T lymphocytes from LPS non-
responders. As depicted in Table II and demonstrated
previously, DNA synthesis to antigens (PPD, donor 1; TT,
donor 2; BCG, donor 3) was not influenced by depletion
or enrichment of CD34
 
1
 
 cells. On the other hand, neither
untreated nor CD34-depleted PBMCs of these LPS nonre-
sponders could be stimulated by LPS. It is noteworthy that
addition of CD34-enriched cells to PBMCs of these donors
clearly resulted in LPS-induced DNA synthesis. Titration
experiments showed that as few as 0.5% CD34
 
1
 
 cells were
able to induce significant DNA synthesis after LPS stimula-
tion (data not shown).
 
CD34
 
1
 
 Blood Stem Cells Are the Responsive Fraction in
Elutriated Monocyte Preparations.
 
In previous experiments,
we have shown that the stimulation of human T lym-
phocytes by LPS depends on the presence of monocytes,
isolated by counter-flow elutriation. The demonstrated
accessory activity of CD34
 
1
 
 blood stem cells prompted ex- 
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periments to investigate whether, in fact, CD34
 
1
 
 stem cells
are responsible for the accessory activity of these monocyte
preparations. The monocyte fractions isolated by counter-
flow elutriation were depleted from CD34
 
1
 
 stem cells by
the MACS
 
®
 
 system. Additionally, CD34
 
1
 
 stem cells were
enriched from monocyte fractions by the MACS
 
®
 
 system
using positive selection. Purified T lymphocytes were iso-
lated from PBMCs by counter-flow elutriation and subse-
quent purification by magnetic depletion of all non-T cells
(CD14
 
1
 
, CD16
 
1
 
, and CD19
 
1
 
 cells). Thereafter, purified T
cells were stimulated with either LPS or PPD in the pres-
ence of unseparated monocytes, CD34-depleted mono-
cytes, or CD34-enriched cells. Table III shows the repre-
sentative results of one of three independent experiments.
Neither LPS nor the recall antigen PPD was able to induce
DNA synthesis in purified T lymphocytes. However, in
the presence of 10% unseparated monocytes, DNA synthe-
sis was observed for both stimuli. Depletion of CD34
 
1
 
 cells
from the elutriated monocyte fractions clearly resulted in
the loss of LPS-induced T cell proliferation, but not of
PPD-induced T cell response. Addition of CD34
 
1
 
 cells not
only restored the response of purified T lymphocytes to
LPS, but resulted in DNA synthesis that was even higher
than in the presence of untreated monocytes. As already
 
Table I.
 
Accessory Cell Activity of CD34
 
1
 
 Blood Stem Cells during Stimulation of T Lymphocytes by LPS
 
Cell population
DNA synthesis after stimulation with
None LPS PPD
 
cpm/culture
 
PBMCs 80 
 
6
 
 10 8,150 
 
6
 
 850 12,630 
 
6
 
 250
CD34-depleted PBMCs 40 
 
6
 
 20 40 
 
6
 
 20 12,060 
 
6
 
 1,690
CD34-depleted PBMCs plus 5% CD34-enriched cells 470 
 
6
 
 130 8,250 
 
6
 
 40 14,430 
 
6
 
 340
PBMCs, labeled with anti-CD34 and GaM microbeads (control 1) 100 
 
6
 
 40 8,150 
 
6
 
 350 11,230 
 
6
 
 120
PBMCs after depletion of cells labeled with an isotype-specific mAb (control 2) 120 
 
6
 
 50 7,980 
 
6
 
 430 12,130 
 
6
 
 380
CD34-enriched cells alone (control 3) 90 
 
6 
 
30 100 
 
6 
 
20 110 
 
6 
 
60
Cells (10
 
6
 
/ml) were stimulated with LPS (
 
S. friedenau
 
, 1 
 
m
 
g/ml) or PPD (1 
 
m
 
g/ml) and cultured for 7 d in RPMI 1640 plus 10% HS in a final volume
of 200 
 
m
 
l/culture. For the last 8 h of culture, cells were pulsed with [
 
3
 
H]TdR (0.2 
 
m
 
Ci/culture), then harvested on glass filter mats, and the radioactivity
was measured in a 
 
b
 
-counter. The results of one of seven experiments are given. Data are expressed as mean 
 
6
 
 SD of three independent cultures.
 
Table II.
 
CD34
 
1
 
 Blood Stem Cells Restore Activation of T Lymphocytes from LPS Nonresponders by LPS
 
Cell population
DNA synthesis after stimulation with
None LPS Recall antigen
 
cpm/culture
 
Experiment 1
PBMCs 680 
 
6 260 520 6 90 12,080 6 1,580
CD34-depleted PBMCs 70 6 10 80 6 10 20,370 6 2,680
CD34-depleted PBMCs plus CD34-enriched cells 590 6 130 8,380 6 110 14,500 6 90
Experiment 2
PBMCs 550 6 290 420 6 10 32,170 6 5,880
CD34-depleted PBMCs 160 6 100 600 6 170 32,640 6 3,950
CD34-depleted PBMCs plus CD34-enriched cells 160 6 40 2,230 6 540 31,700 6 2,640
Experiment 3
PBMCs 140 6 50 250 6 80 2,110 6 910
CD34-depleted PBMCs 350 6 40 390 6 60 2,490 6 120
CD34-depleted PBMCs plus CD34-enriched cells 770 6 240 12,010 6 1,200 3,370 6 1,030
Cells (106/ml) plus 10% accessory cells were stimulated with LPS (S. friedenau, 1 mg/ml), TT (donor 1, 1 Lf/ml), PPD (donor 2, 1 mg/ml), or BCG
(donor 3, 4,000 CFU/ml) and cultured for 7 d in RPMI 1640 plus 10% HS in a final volume of 200 ml/culture. For the last 8 h of culture, cells were
pulsed with [3H]TdR (0.2 mCi/culture), then harvested on glass filter mats, and the radioactivity was measured in a b-counter. Data are expressed as
mean 6 SD of three independent cultures.696 Accessory Function of CD341 Blood Stem Cells
shown for PBMCs, depletion or enrichment of CD341
cells from elutriated monocytes had no influence on PPD-
induced T cell proliferation.
CD341 Blood Stem Cells Are Necessary for the Induction of
CD80 on Monocytes after LPS Stimulation. Previously, we
have reported that stimulation of human T lymphocytes by
LPS is dependent on the interactions of CD80 (B7.1) on
accessory cells and CD28 on T cells (14). We have also
shown that CD80 could be induced on monocytes of LPS
responders, but not on monocytes of LPS nonresponders
after LPS stimulation. To shed light on the role of CD341
blood stem cells in the expression of CD80, we now com-
pared the CD80 expression on monocytes after LPS stimu-
lation in unseparated PBMCs, CD34-depleted PBMCs,
and CD34-depleted PBMCs plus CD34-enriched cells. As
a control, DNA synthesis was determined. In Table IV,
one representative experiment of three independent exper-
iments is shown. CD80 expression on monocytes after LPS
stimulation was clearly dependent on the presence of
CD341 accessory cells. After LPS stimulation of unsepa-
rated PBMCs, CD80 was enhanced on monocytes. Deple-
tion of CD341 cells resulted in a diminished stimulation of
DNA synthesis as well as reduced CD80 expression after
LPS stimulation. The addition of CD34-enriched cells to
CD34-depleted PBMCs not only restored but even sur-
passed DNA synthesis as well as CD80 expression after LPS
stimulation compared with PBMC controls.
CD341 Blood Stem Cells Are Necessary for the Production of
IFN-g. In previous experiments, we have shown that
LPS is a potent inducer of IFN-g production by human T
lymphocytes (13). In the experiments presented here, we
investigated whether depletion of CD341 blood stem cells
also influences the production of IFN-g by PBMCs. As
shown in Fig. 1, IFN-g production was clearly reduced in
the absence of CD341 cells over the total culture period of
4 d. On the other hand, IFN-g production could be fully
restored by adding CD341 cells. It should be noted that
IFN-g could be detected in PBMCs or CD342 PBMCs
plus CD341 cells already after 1–2 h of culture (data not
given).
CD341 Blood Stem Cells Cannot Be Replaced by Dendritic
Cells Derived from Blood Monocytes. CD341 blood stem
cells are described to be a source for the in vitro generation
of dendritic Langerhans cells (17–21). These dendritic
Langerhans cells were shown to be highly efficient in pro-
cessing and presenting soluble antigens to autologous T
Table III. Failure of CD34-depleted Monocytes to Exert Accessory Function during Stimulation of T Lymphocytes by LPS
Cell population
DNA synthesis after stimulation with
None LPS PPD
cpm/culture
Purified T lymphocytes 190 6 70 210 6 140 250 6 180
T plus 10% monocytes 220 6 20 3,600 6 320 9,370 6 1,380
T plus 10% CD34-depleted cells 210 6 20 350 6 50 12,300 6 3,350
T plus 10% CD34-enriched cells 600 6 290 8,520 6 90 8,600 6 380
Purified T lymphocytes (106/ml) or T lymphocytes plus 10% of the accessory cell preparations described above were stimulated with LPS (S. friede-
nau, 1 mg/ml), or PPD (1 mg/ml) and cultured for 7 d in RPMI 1640 plus 10% HS in a final volume of 200 ml/culture. For the last 8 h of culture,
cells were pulsed with [3H]TdR (0.2 mCi/culture), then harvested on glass filter mats, and the radioactivity was measured in a b-counter. The results
of one of three experiments are given. Data are expressed as mean 6 SD of three independent cultures.
Table IV. CD341 Blood Stem Cells Are Necessary for LPS-induced Expression of CD80 on Monocytes
Cell population
CD80 expression DNA synthesis
None LPS None LPS
% positive monocytes cpm/culture
PBMCs 15.6 58.2 220 6 70 7,160 6 340
CD34-depleted PBMCs 16.2 21.6 210 6 110 590 6 230
CD34-depleted PBMCs plus CD34-enriched cells 13.3 80.1 340 6 160 11,720 6 1,080
Cells (106/ml) were stimulated with LPS (S. friedenau, 1 mg/ml) and cultured in RPMI 1640 plus 10% HS in a final volume of 200 ml/culture.
CD80 expression was measured after 2 d of culture. For determination of DNA synthesis after 7 d of culture, cells were pulsed with [3H]TdR (0.2
mCi/culture) for the last 8 h of culture, then harvested on glass filter mats, and the radioactivity was measured in a b-counter. The results of one of
three experiments are given. Data are expressed as mean 6 SD of three independent cultures.697 Mattern et al.
lymphocytes (20). Thus, we asked whether LPS induces
the generation of dendritic cells from CD341 blood stem
cells in the system described. Therefore, it was analyzed
whether CD341 stem cells could be replaced by autolo-
gous dendritic cells. To obtain dendritic cells, peripheral
blood monocytes were isolated by counter-flow elutriation
and cultured for 2 wk in the presence of GM-CSF, IL-4,
and IFN-g. After this culture period, the cells had the typi-
cal morphology of dendritic cells and could be phenotypi-
cally characterized by the following surface structures:
CD14, 4.9 6 2.5%; HLA-DR, 90 6 7%; CD80, 47.5 6
6%; and CD86, 53 6 16%. The accessory capacity of these
dendritic cells was compared with the accessory capacity of
freshly isolated monocytes. As shown in Fig. 2, freshly iso-
lated monocytes induce significantly higher DNA synthesis
after LPS stimulation than dendritic cells. As expected,
dendritic cells function as accessory cells after stimulation
with TT. From these experiments, we concluded that it is
the CD341 blood stem cell and not the dendritic cell
which provides accessory capacity in LPS-induced T cell
proliferation.
CD341 Blood Stem Cells Can Be Replaced by KG-1a
Cells. The purity of our CD34-enriched blood stem cell
preparations varied between 45 and 85%. This raised the
question, whether other cell populations present may con-
tribute to the observed effects in addition to or instead of
CD341 blood stem cells. Therefore, a myeloid stem cell
line was used to replace accessory cell preparations used.
Indeed, it was found that the hematopoietic stem cell line
KG-1a, derived from an acute myelogenous leukemia (22),
was able to substitute for CD341 blood stem cell prepara-
tions. Purified T lymphocytes were cultured in the pres-
ence of g-irradiated KG-1a cells and stimulated with LPS.
Table V shows representative results of eight experiments.
It was found that, indeed, T lymphocytes responded to LPS
in the presence of KG-1a cells. Furthermore, controls with
irradiated KG-1a cells showed that the resulting DNA syn-
thesis was not due to proliferating KG-1a cells.
Discussion
The factors and mechanisms involved in stimulation of
human or murine T lymphocytes by LPS are not yet fully
understood. All features of T cell stimulation indicate a
new, so far unknown mechanism of T cell activation by
LPS: LPS is not a T cell mitogen (low frequency of re-
sponding cells), a T cell superantigen (living accessory cells
Figure 1. Accessory cell activity of CD341 blood stem cells during in-
duction of IFN-g release in T lymphocytes by LPS. PBMCs (106/ml),
CD34-depleted PBMCs (106/ml), or CD34-depleted PBMCs plus 5%
CD341 cells were cultured in 24-well plates (1 ml/well) in RPMI 1640
plus 10% HS. Cells were stimulated with LPS (1 mg/ml; black bars); con-
trol cultures remained unstimulated (white bars). After 24, 48, or 96 h of
culture, supernatants were harvested and IFN-g production was measured
in an ELISA. Data are expressed as mean 6 SD of duplicate cultures.
Figure 2. Accessory activity of monocytes and dendritic cells during
stimulation of T cells by LPS. Purified T lymphocytes (106/ml) were cul-
tured in the presence of 10% freshly isolated autologous monocytes
(white bars) or 10% autologous dendritic cells (black bars) and stimulated
with LPS (S. friedenau, 1 mg/culture) in RPMI 1640 plus 10% HS in a fi-
nal volume of 200 ml/culture. After 7 d of culture, cells were pulsed with
[3H]TdR (0.2 mCi/culture), then harvested on glass filter mats, and the
radioactivity was measured in a b-counter. The results of one of three ex-
periments are given. Data are expressed as mean 6 SD of three indepen-
dent cultures.
Table V. KG-1a Stem Cell Line Shows Accessory Activity during 
Stimulation of T Lymphocytes by LPS
Cell population
DNA synthesis after
stimulation with
None LPS
cpm/culture
T 110 6 10 430 6 90
T plus irradiated KG-1a 320 6 200 25,180 6 2,700
Irradiated KG-1a 280 6 130 380 6 90
Purified T lymphocytes (106/ml) were cultured in the presence of 10%
irradiated (5,000 rads) KG-1a cells and stimulated with LPS (S. friede-
nau, 1 mg/ml) in RPMI 1640 plus 10% HS in a final volume of 200 ml/
culture. After 7 d of culture, cells were pulsed with [3H]TdR (0.2 mCi/
culture), then harvested on glass filter mats, and the radioactivity was
measured in a b-counter. The results of one of eight experiments are
given. Data are expressed as mean 6 SD of three independent cultures.698 Accessory Function of CD341 Blood Stem Cells
and CD80–CD28 interactions are necessary), or a classical
T cell antigen (no MHC-restricted interactions between
APCs and T lymphocytes) (13, 14). Furthermore, it may be
speculated that LPS, as a lipid antigen, might be presented
(like lipoarabinomannan [LAM]) by CD1 in an MHC-
unrestricted manner. However, monocytes, stem cells, or
KG-1a cells do not express CD1; therefore, this mechanism
of stimulation can be excluded. CD80 expression and IL-12
have been reported to stimulate proliferation and cytokine
production in T lymphocytes (23–25). These data might
suggest that LPS stimulates T lymphocytes by this indirect
mechanism. However, the low frequency of responding T
cells after LPS stimulation (1:1,000; reference 13) excludes
this rather unspecific activation mechanism by CD80 and
IL-12 alone.
The unique and new characteristic feature of T cell stim-
ulation by LPS is underlined by the results presented in this
paper. The necessity of hematopoietic blood stem cells for
activation of T cells by LPS represents a new mechanism of
T cell activation and introduces stem cells as active, potent
cells in inflammatory reactions mediated by T lymphocytes.
Peripheral CD341 blood stem cells are known to be a
source for autologous and allogenic stem cell transplanta-
tion and have been introduced for the treatment of hema-
tological malignancies (26, 27). Furthermore, these cells
have been described to be a source for the in vitro genera-
tion of dendritic Langerhans cells by treatment of bone
marrow or blood stem cells with GM-CSF and TNF-a
(17, 18, 20, 21). These dendritic Langerhans cells were
shown to be highly efficient in processing and presenting
soluble antigen to autologous T lymphocytes (20). How-
ever, an accessory function of freshly isolated CD341 blood
stem cells has not been documented to date. We can only
speculate on the mechanisms by which CD341 blood stem
cells exert their accessory functions. We consider it un-
likely that LPS induces the generation of dendritic cells
from CD341 blood stem cells in our system. Time–kinetic
studies concerning the production of IFN-g after LPS
stimulation as shown in Fig. 1 or the expression of CD80
on monocytes after 2 d of culture (Table IV) argue against
this hypothesis. IFN-g could already be detected after a
few hours of stimulation of PBMCs or CD342 PBMCs
plus CD34-enriched cells by LPS (Fig. 1, and our unpub-
lished data). However, as demonstrated by others, for the
generation of dendritic cells, culture periods of several days
are necessary (17–21). Furthermore, classical dendritic cells
generated from elutriated monocytes by treatment with
IFN-g, IL-4, and GM-CSF were clearly less efficient than
freshly isolated monocyte preparations (Fig. 2).
It has also not been clear whether CD341 blood stem
cells act directly as accessory cells for the induction of T cell
proliferation or indirectly by influencing the function of
monocytes, which are always present at low numbers in the
CD34-enriched blood stem cell preparations. The require-
ment for CD80–CD28 interaction for T cell stimulation by
LPS and the requirement of CD341 stem cells for CD80
expression on monocytes, together with the results ob-
tained with the KG-1a cell line, argue for the latter hy-
pothesis. This question still requires clarification and is
presently under further investigation.
In conclusion, the activation of T lymphocytes by LPS
represents a new and unique mechanism of T cell activa-
tion differing from that induced by classical mitogens, su-
perantigens, or antigens. The involvement of hematopoi-
etic blood stem cells in this type of activation demonstrated
for the first time a new role of these cells in inflammatory
and immunological events. The significance of these find-
ings for the medication and prevention of diseases (e.g.,
septic shock, bone marrow transplantation, stem cell factor
treatment) remains to be investigated.
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